SākumlapaIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
35,29 $
Pēc biržas darba laika:(4,17%)-1,47
33,82 $
Slēgts: 6. jūn., 16:53:42 GMT-4 · USD · NASDAQ · Atruna
Slēgšanas kurss
35,24 $
Dienas diapazons
35,00 $ - 35,88 $
Gada diapazons
23,95 $ - 52,34 $
Tirgus kapitalizāc.
5,62 mljrd. USD
Vid. apjoms
1,53 milj.
P/E koeficients
-
Ienākumi no dividendēm
-
Galvenā birža
NASDAQ
Tirgus ziņas
Par
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Ģenerāldirektors
Dibināšanas datums
1989
Galvenais birojs
Tīmekļa vietne
Darbinieki
1 069
